Rifampin, Isoniazid and Pyrazinamide Articles
Rifater Marketed In USA
14 November 1994
Mixed Results From US Companies In 2nd Qtr
8 August 1994
MMD RECEIVES FDA OK FOR RIFATER
13 June 1994
US NDA FILED FOR RIFATER
12 July 1993
Showing 1-4 of 4 articles
- 1
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
